Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Ionis Pharmaceuticals Inc (IONS)  
$40.16 0.77 (1.88%) as of 4:30 Wed 5/8


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 143,470,000
Market Cap: 5.76(B)
Last Volume: 998,037 Avg Vol: 995,265
52 Week Range: $35.18 - $53.55
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  292
Guru Rank Value     : 4.1
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Ionis Pharmaceuticals is engaged in RNA-targeted therapeuty. Co.'s commercial products are SPINRAZA, TEGSEDI and WAYLIVRA. SPINRAZA injection for intrathecal use is a survival motor neuron-2 directed antisense medicine indicated for the treatment of spinal muscular atrophy in pediatric and adult patients. TEGSEDI injection is an RNA-targeted medicine indicated for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. WAYLIVRA is an antisense medicine indicated as an adjunct to diet in adult patients with genetically confirmed FCS and at high risk for pancreatitis, in whom response to diet and triglyceride lowering therapy has been inadequate.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 11,298 469,764 507,366 634,895
Total Sell Value $477,835 $23,553,002 $25,162,121 $30,224,270
Total People Sold 4 12 13 13
Total Sell Transactions 4 44 52 78
End Date 2024-02-09 2023-11-08 2023-05-10 2022-05-10

   
Records found: 1983
  Page 9 of 80  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bennett C Frank EVP, Chief Scientific Officer   •       –      –    2022-01-18 4 OE $0.00 $0 D/D 18,842 61,613     -
   Monia Brett P Chief Executive Officer   •       •      –    2022-01-18 4 D $30.12 $593,786 D/D (19,714) 80,230     -
   Monia Brett P Chief Executive Officer   •       •      –    2022-01-18 4 OE $0.00 $0 D/D 49,475 99,944     -
   Cadoret-Manier Onaiza EVP, Chf Corp Dev and Cml Offc   •       –      –    2022-01-18 4 D $30.12 $69,427 D/D (2,305) 8,382     -
   Cadoret-Manier Onaiza EVP, Chf Corp Dev and Cml Offc   •       –      –    2022-01-18 4 OE $0.00 $0 D/D 6,057 10,687     -
   Oneil Patrick R. EVP CLO & General Counsel   •       –      –    2022-01-18 4 D $30.12 $225,930 D/D (7,501) 40,593     -
   Oneil Patrick R. EVP CLO & General Counsel   •       –      –    2022-01-18 4 OE $0.00 $0 D/D 21,086 48,094     -
   Geary Richard S EVP, Chief Development Officer   •       –      –    2022-01-18 4 D $30.12 $229,063 D/D (7,605) 55,752     -
   Geary Richard S EVP, Chief Development Officer   •       –      –    2022-01-18 4 OE $0.00 $0 D/D 21,391 63,357     -
   Swayze Eric EVP Research   •       –      –    2022-01-18 4 D $30.12 $150,419 D/D (4,994) 20,110     -
   Swayze Eric EVP Research   •       –      –    2022-01-18 4 OE $0.00 $0 D/D 13,809 25,104     -
   Hougen Elizabeth L EVP, Finance & CFO   •       –      –    2022-01-18 4 D $30.12 $235,779 D/D (7,828) 57,975     -
   Hougen Elizabeth L EVP, Finance & CFO   •       –      –    2022-01-18 4 OE $0.00 $0 D/D 22,050 65,803     -
   Parshall B Lynne Director   –       •      –    2022-01-18 4 D $30.12 $49,758 D/D (1,652) 77,480     -
   Parshall B Lynne Director   –       •      –    2022-01-18 4 OE $0.00 $0 D/D 5,754 79,132     -
   Reikes Peter N Director   –       •      –    2021-10-15 4 OE $0.00 $0 D/D 1,777 14,222     -
   Schneider Eugene EVP, Chf Clinical Develop Offc   •       –      –    2021-10-15 4 D $35.10 $5,090 D/D (145) 7,175     -
   Schneider Eugene EVP, Chf Clinical Develop Offc   •       –      –    2021-10-15 4 OE $0.00 $0 D/D 417 7,320     -
   Hayden Michael R Director   –       •      –    2021-10-15 4 OE $0.00 $0 D/D 1,777 14,222     -
   Monia Brett P Chief Executive Officer   •       •      –    2021-08-31 4 A $33.80 $11,998 D/D 355 50,469     -
   Geary Richard S EVP, Chief Development Offc   •       –      –    2021-08-31 4 A $33.80 $1,555 D/D 46 41,966     -
   Oneil Patrick R. EVP Legal & General Counsel   •       –      –    2021-08-31 4 A $33.80 $10,443 D/D 309 27,008     -
   Hougen Elizabeth L EVP, Finance & CFO   •       –      –    2021-08-31 4 A $33.80 $5,610 D/D 166 43,753     -
   Cadoret-Manier Onaiza Chief Corp Dev and Cml Officer   •       –      –    2021-08-31 4 A $33.80 $14,566 D/D 431 4,630     -
   Bennett C Frank EVP & Chief Scientific Officer   •       –      –    2021-08-31 4 A $33.80 $5,103 D/D 151 42,771     -
  1983 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 80
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us